Newark Beth Israel Medical Center — Newark, New Jersey

Newark Beth Israel Medical Center is a clinical research site located in Newark, New Jersey, United States 07112.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Newark Beth Israel Medical Center has participated in 394 clinical trials with 111 currently active.

Therapeutic areas: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.

Sponsors: Children's Oncology Group, Afimmune, NSABP Foundation Inc.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Newark Beth Israel Medical Center?

Newark Beth Israel Medical Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Newark Beth Israel Medical Center conducted?

Newark Beth Israel Medical Center has 394 clinical trials on record, with 111 currently active. Their work covers B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.

Is Newark Beth Israel Medical Center accredited by Crixeo Health?

Newark Beth Israel Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Newark Beth Israel Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.